STK38 and prostate cancer: Our previous work has shown that NDR1 inhibits the metastasis of prostate cancer cells by suppressing epithelial-mesenchymal transition (EMT), and decreased NDR1 expression might lead to a poorer prognosis in patients (Yue et al., 2018).